| FHCCX | FSPHX | FHCCX / FSPHX | |
| Total Expense Ratio | 1.68 | 0.63 | 267% |
| Annual Report Gross Expense Ratio | 1.68 | 0.63 | 267% |
| Fund Existence | 28 years | 45 years | - |
| Gain YTD | 0.814 | 0.809 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.25B | 6.28B | 52% |
| Annual Yield % from dividends | 0.00 | 0.43 | - |
| Returns for 1 year | -9.50 | 0.29 | -3,300% |
| Returns for 3 years | -15.86 | 1.47 | -1,078% |
| Returns for 5 years | -27.46 | -13.13 | 209% |
| Returns for 10 years | 37.56 | 62.61 | 60% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIDFX | 59.76 | 0.32 | +0.54% |
| Marsico Midcap Growth Focus Instl | |||
| FBTTX | 34.88 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||
| TDFIX | 9.25 | -0.02 | -0.22% |
| Transamerica Sustainable Equity Inc I | |||
| HROAX | 12.40 | -0.07 | -0.56% |
| M3Sixty Income and Opportunity A | |||
| VPRAX | 26.68 | -0.19 | -0.71% |
| VY® T. Rowe Price Capital Apprec R6 | |||